X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (633) 633
octamer transcription factor-1 (536) 536
host cell factor c1 (497) 497
animals (464) 464
transcription factors - metabolism (413) 413
dna-binding proteins - metabolism (395) 395
base sequence (347) 347
molecular sequence data (345) 345
biochemistry & molecular biology (320) 320
index medicus (275) 275
mice (274) 274
promoter regions, genetic (247) 247
transcription factors - genetics (212) 212
cell biology (198) 198
binding sites (196) 196
dna-binding proteins - genetics (191) 191
octamer transcription factor-1 - metabolism (184) 184
cell line (169) 169
octamer transcription factor-1 - genetics (158) 158
transcription, genetic (157) 157
expression (150) 150
gene expression regulation (150) 150
female (135) 135
protein binding (134) 134
amino acid sequence (125) 125
gene expression (120) 120
transfection (119) 119
gene-expression (118) 118
hela cells (115) 115
male (111) 111
transcription factors (110) 110
octamer transcription factor-2 (107) 107
research article (107) 107
oct-1 (106) 106
cells, cultured (105) 105
dna - metabolism (101) 101
activation (100) 100
transcriptional activation (100) 100
homeodomain proteins - metabolism (95) 95
dna (94) 94
research (92) 92
rats (88) 88
genetics & heredity (81) 81
promoter (81) 81
promoter regions, genetic - genetics (80) 80
tumor cells, cultured (80) 80
proteins (79) 79
oncology (76) 76
transcription factor (76) 76
protein (75) 75
transcription (75) 75
pou domain (74) 74
genetic aspects (72) 72
trans-activators - metabolism (71) 71
analysis (69) 69
octamer transcription factor-3 - metabolism (69) 69
cell line, tumor (68) 68
transcription factors - chemistry (66) 66
transcription factors - physiology (66) 66
dna-binding proteins - physiology (65) 65
genes (65) 65
mutation (65) 65
differentiation (64) 64
dna-binding (64) 64
octamer transcription factor-3 - genetics (64) 64
article (63) 63
nuclear proteins - metabolism (61) 61
rna, messenger - genetics (61) 61
dna-binding proteins - chemistry (59) 59
homeodomain proteins - genetics (59) 59
pou-domain (58) 58
stem cells (57) 57
cell differentiation (55) 55
multidisciplinary sciences (55) 55
dna - genetics (54) 54
enhancer elements, genetic (54) 54
rna, messenger - metabolism (54) 54
binding (53) 53
immunology (53) 53
trans-activators - genetics (53) 53
cloning, molecular (51) 51
adult (50) 50
physiological aspects (50) 50
binding sites - genetics (49) 49
signal transduction (49) 49
genetic transcription (48) 48
cells (46) 46
mutagenesis, site-directed (46) 46
cancer (45) 45
dna binding proteins (45) 45
phosphorylation (45) 45
gene (44) 44
polymerase chain reaction (44) 44
embryonic structures (43) 43
reverse transcriptase polymerase chain reaction (43) 43
middle aged (42) 42
regulatory sequences, nucleic acid (42) 42
cell nucleus - metabolism (41) 41
pharmacology & pharmacy (41) 41
recombinant fusion proteins - metabolism (41) 41
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2014, Volume 111, Issue 27, pp. 9983 - 9988
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2013, Volume 110, Issue 27, pp. 11199 - 11204
Journal Article
Molecular Systems Biology, ISSN 1744-4292, 2013, Volume 9, Issue 1, pp. 637 - n/a
Journal Article
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 05/2018, Volume 103, Issue 5, pp. 758 - 760
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 14, pp. 2381 - 2388
Purpose There is a considerable variability in the level of molecular responses achieved with imatinib therapy in patients with chronic myeloid leukemia (CML).... 
OCT-1 ACTIVITY | THERAPY | CHRONIC-PHASE | ONCOLOGY | KINASE DOMAIN MUTATIONS | STANDARD-DOSE IMATINIB | SUBOPTIMAL RESPONSE | NONADHERENCE | DETERMINANT | CML PATIENTS | BCR-ABL TRANSCRIPTS | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Antineoplastic Agents - therapeutic use | RNA, Messenger - metabolism | Young Adult | Time Factors | Aged, 80 and over | Adult | Drug Monitoring - instrumentation | Female | Antineoplastic Agents - pharmacokinetics | Micro-Electrical-Mechanical Systems - instrumentation | Cytogenetic Analysis | Piperazines - pharmacokinetics | Protein Kinase Inhibitors - pharmacokinetics | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Octamer Transcription Factor-1 - genetics | Piperazines - therapeutic use | Gene Expression Regulation, Leukemic | Imatinib Mesylate | ATP Binding Cassette Transporter, Subfamily B | ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics | Polymorphism, Genetic | Fusion Proteins, bcr-abl - genetics | Medication Adherence | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - pharmacokinetics | Aged | Benzamides | Mutation | Hema7 | ORIGINAL REPORTS | Hema5
Journal Article